Studies of Glyoxalase 1-Linked Multidrug Resistance Reveal Glycolysis-Derived Reactive Metabolite, Methylglyoxal, Is a Common Contributor in Cancer Chemotherapy Targeting the Spliceosome
<h3>Background</h3><p dir="ltr">Tumor glycolysis is a target for cancer chemotherapy. Methylglyoxal (MG) is a reactive metabolite formed mainly as a by-product in anaerobic glycolysis, metabolized by glyoxalase 1 (Glo1) of the glyoxalase system. We investigated the role o...
محفوظ في:
| المؤلف الرئيسي: | Muhanad Alhujaily (11630107) (author) |
|---|---|
| مؤلفون آخرون: | Hafsa Abbas (9501821) (author), Mingzhan Xue (3607649) (author), Alberto de la Fuente (360936) (author), Naila Rabbani (291722) (author), Paul J. Thornalley (291723) (author) |
| منشور في: |
2021
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Emerging Glycation-Based Therapeutics—Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors
حسب: Naila Rabbani (291722)
منشور في: (2022) -
Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity—Opportunity for Repurposed Chemotherapy of COVID-19 Infection
حسب: Maryam S. Al-Motawa (9501818)
منشور في: (2020) -
Hexokinase-2-Linked Glycolytic Overload and Unscheduled Glycolysis—Driver of Insulin Resistance and Development of Vascular Complications of Diabetes
حسب: Naila Rabbani (291722)
منشور في: (2022) -
Decreased methylglyoxal-mediated protein glycation in the healthy aging mouse model of ectopic expression of UCP1 in skeletal muscle
حسب: Jinit, Masania
منشور في: (2023) -
Decreased methylglyoxal-mediated protein glycation in the healthy aging mouse model of ectopic expression of UCP1 in skeletal muscle
حسب: Jinit Masania (7164239)
منشور في: (2023)